Rocket scientist-turned-immunology expert Mark Kendall talks about his Nanopatch, which could revolutionise vaccinations and eradicate some diseases.
Mark Kendall (born 1972) is an Australian biomedical engineer and innovator. He is an Entrepreneurial Professor of the Australian National University. His field of research is the delivery of immunotherapeutics to the skin without the use of a needle or syringe.
In 2011, he co-founded the development company Vaxxas with an investor syndicate. The company’s technology, called Nanopatch, is intended to serve as a needle-free vaccine delivery device. In 2011, Kendall and his AIBN team received the Australian Research Council Eureka Prize for Excellence in Research by an Interdisciplinary Team. In 2012, he was awarded the Rolex Awards for Enterprise for his “pioneering efforts to expand knowledge and improve human life”.
Listen to the latest science updates, with Benjamin Thompson and Shamini Bundell. This week, insights into the evolution of walking upright, how science needs to change in the next 150 years, and the remaining hurdles for vaccination.
This year is Nature’s 150th anniversary. Science has made huge strides during this time, but what needs to change to continue this progress for the next 150 years? Comment: Science must move with the times
17:52 The state of vaccination in 2019
Researchers assess the differences in immunization levels worldwide and identify the bottlenecks in developing new vaccines. Research article: Piot et al.